Drug Target Review

APRIL 19, 2024

Sibylla’s scientific founders come from very different scientific fields that do not usually speak to each other, such as theoretical physics, molecular biology and pharmaceutical chemistry. And so, I have been the managerial co-founder and CEO of Sibylla since 2017. This multidisciplinary approach is at the heart of Sibylla.

Molecular Biology 111

Molecular Biology Research Pharmaceuticals Small Molecule 111

Elrig

APRIL 29, 2024

Jasmine has a background in neuroscience and genetic manipulation, with early works focused on using a combined structural and molecular biology approach to assess disease-associated proteins implicated in Alzheimer’s disease. big pharma or startups/spin off? Where do you enjoy more to work? What pro/cons?

Bioinformatics 59

Bioinformatics Drugs Molecular Biology Cell Based Assays 59

Vial

MARCH 1, 2024

A 2022 survey by McKinsey found that emerging biotech companies are less satisfied with their CROs than large pharma companies and reported the feeling of being underserved. Based in Massachusetts, Thermo Fisher Scientific Inc.

Clinical Trials 52

Clinical Trials Clinical Research Trials Laboratories 52

Codon

FEBRUARY 13, 2024

” A Global View Even as advances in computing and molecular biology usher in the era of a new, high-tech “phage therapy 2.0”, ” “Somebody’s just got to break through with good data, even if it’s not us.

Therapies 119

Therapies Virus DNA Clinical Trials 119